Skip to content
healthcare.dev

ORENCIA

NDC 0003-2818, abatacept, injection, solution, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-2818
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125118
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2818 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABATACEPT87.5 mg/.7mL

Pharmacologic classes

Decreased Cytokine Activity [PE]; Recombinant Fusion Proteins [CS]; Selective T Cell Costimulation Modulator [EPC]

Package NDCNDC-11Package
0003-2818-11000032818114 SYRINGE, GLASS in 1 CARTON (0003-2818-11) / .7 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0836c6ac-ee37-5640-2fed-a3185a0b16eb
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0003-2818

Use it

Look up 0003-2818 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2818 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-2818. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.